ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.

Gary N Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.